Clinical Trials Logo

Clinical Trial Summary

Recruited patients should receive the endoscopic surgery for picking the olfactory mucosa 1 to 2 months before transplantation. The Olfactory Ensheathing Cells (OECs) will be cultured and expanded under the rule of GTP. Then, quality control of OECs should be done by immunohistochemical staining positive for GFAP, S100, and P75. Finally, the investigators will transplant the OECs (about 2 to 8 X 10´6 cells in saline) into the peri-infarcted area of the brain.


Clinical Trial Description

(1)Recruited patients should receive the endoscopic surgery for picking the olfactory mucosa 1 to 2 months before transplantation. The OECs will be cultured and expanded under the rule of GTP. Then, quality control of OECs should be done by immunohistochemical staining positive for GFAP, S100, and P75. Finally, the investigators will transplanted the OECs (about 2 to 8 X 10´6 cells in saline) into the peri-infarcted area of the brain. (2) Combination with traditional drug therapy (such as used the anti-thrombosis reagent or anti-platelet aggregation reagent). (3) NIH-stroke scale (NIHSS), European stroke scale (ESS), European stroke motor subscale (EMS), Barthel Index(BI) and MMSE will be performed for each patient to evaluate the therapeutic effect as the primary end points. (4) In addition, MRI(DTI) & TMS(MEP) will be also checked for each recruitment patient as the secondary end points. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01327768
Study type Interventional
Source China Medical University Hospital
Contact Hsiao-Jung Wang, M.S.
Phone 886-4-22052121
Email city6364@yahoo.com
Status Recruiting
Phase Phase 1
Start date January 2011
Completion date May 2013

See also
  Status Clinical Trial Phase
Terminated NCT02016547 - Thrombectomy Under Reopro Versus Alteplase to Treat Stoke Phase 4
Completed NCT00761982 - Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Phase 1/Phase 2
Completed NCT00535197 - Autologous Bone Marrow Stem Cells in Ischemic Stroke. Phase 1/Phase 2
Recruiting NCT05899582 - Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial N/A
Completed NCT01468064 - Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke Phase 1/Phase 2
Completed NCT04292600 - Testing of Identification Markers for Stroke
Suspended NCT03098732 - Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial N/A
Completed NCT01113645 - Impact of Cranioplasty On Cerebral Perfusion N/A
Completed NCT03679364 - An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam
Not yet recruiting NCT01438593 - Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke Phase 1
Completed NCT02594137 - A Comparison Between Two Techniques for Performing Decompressive Craniectomy N/A
Completed NCT00604630 - Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke Phase 2/Phase 3
Recruiting NCT04093336 - Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients Phase 1/Phase 2
Completed NCT00473057 - Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke Phase 1